Product Information
EZETIMIBE-SIMVASTATIN 10-10 MG is a generic product labeled by Actavis Pharma, Inc., priced at $0.3662 per EA under NDC 45963056530. Its NADAC has been published 450 times since Jul 19, 2017.
Strength
10; 10 mg/1; mg/1
Manufacturer
Actavis Pharma, Inc.NDC
45963056530
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
EZETIMIBE; SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA202968On Market Since
4/26/2017
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE-SIMVASTATIN 10-10 MG has been published 450 times since Jul 19, 2017, and over the history we have for it it has declined 85.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3662 per EA |
|---|---|
| All-time high | $3.2377 (Jan 10, 2018) |
| All-time low | $0.2356 (Apr 19, 2023) |
| 52-week high | $0.3662 |
| 52-week low | $0.2639 |
| Median price | $0.7963 |
| Average price | $1.1296 |
| Largest weekly change | +75.7% (May 17, 2023) |
| Weeks tracked | 450 |
| Tracking since | Jul 19, 2017 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EZETIMIBE-SIMVASTATIN 10-10 MG?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE-SIMVASTATIN 10-10 MG, manufactured by Actavis Pharma, Inc., is $0.3662 per EA (NDC 45963056530), effective Feb 25, 2026.
How has the price of EZETIMIBE-SIMVASTATIN 10-10 MG changed over time?
Over the history we have for it, the NADAC for EZETIMIBE-SIMVASTATIN 10-10 MG has declined 85.5%. It has been tracked across 450 weekly CMS publications since Jul 19, 2017.
What are the highest and lowest recorded NADAC prices for EZETIMIBE-SIMVASTATIN 10-10 MG?
Since Jul 19, 2017, the NADAC for EZETIMIBE-SIMVASTATIN 10-10 MG has ranged from a low of $0.2356 (Apr 19, 2023) to a high of $3.2377 (Jan 10, 2018), with a median of $0.7963 per EA.
Are there cheaper alternatives to EZETIMIBE-SIMVASTATIN 10-10 MG?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, EZETIMIBE-SIMVASTATIN 10-10 MG, is $0.3246 per EA — about 11% below EZETIMIBE-SIMVASTATIN 10-10 MG.
Who manufactures EZETIMIBE-SIMVASTATIN 10-10 MG?
EZETIMIBE-SIMVASTATIN 10-10 MG (NDC 45963056530) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification